Diego Pizzagalli, PhD - ADAA Board Member

Diego Pizzagalli, PhD
McLean Hospital

Dr. Pizzagalli received his M.A. (1995) and Ph.D. (1998) from the University of Zurich, Switzerland and did post-doctoral work at University of Wisconsin, Madison. From 2002-2010 he was a faculty member in the Department of Psychology at Harvard University, where he served as the John and Ruth Hazel Associate Professor of the Social Sciences. In 2010, he was recruited to McLean Hospital to serve as the Founding Director of the newly established Center for Depression, Anxiety and Stress Research (CDASR), as well as the Director of the McLean Imaging Center (MIC). Under his leadership, CDASR has grown to over 60 full-time staff, and has been awarded over $60 millions in funding. Since September 2015, Dr. Pizzagalli also serves as the Director of Research for the Division of Depression and Anxiety. He is currently a Professor of Psychiatry at Harvard Medical School, and the Center Director for a Silvio O. Conte Center for Basic Translational Mental Health Research focused on the neurobiology of and novel treatment targets for depression and anxiety disorders. Starting in 2024, he will be a visiting professor at Oxford University.

The main goals of his research are to improve our understanding of the psychological, environmental, and neurobiological factors associated with mood disorders, particularly major depression. To this end, he integrates behavioral, electrophysiological, neuroimaging, and, more recently, pharmacological approaches to investigate three putative endophenotypes of depression: anhedonia (loss of pleasure), increased stress sensitivity, and executive function deficits.

Dr. Pizzagalli has published over 360 papers and chapters and serves on the editorial board of 13 journals. He is the Editor-In-Chief for the journal Cognitive, Affective and Behavioral Neuroscience, as well as the Principal Editor for Psychopharmacology (Human Psychopharmacology: Experimental).

Among several awards, he received the Distinguished Scientific Award for an Early Career Contribution to Psychophysiology from the Society for Psychophysiological Research (2006), the Early Career Award from the EEG and Clinical Neuroscience Society (2007), the Anne M. Cataldo Excellence in Mentoring Award from McLean Hospital (2015), two MERIT awards from the National Institute of Mental Health (2016, 2022), The Stuart T. Hauser, M.D. PhD. Mentorship Award in Psychiatry from Harvard Medical School (2017), the Joel Elkes Research Award from the American College of Neuropsychopharmacology (2017), a NARSAD Distinguished Investigator Award (2018), and the Anna-Monika-Prize for Research in the Neurobiology and Treatment of Depressive Disorders (2019). Since 2019, he has been a Highly Cited Researcher according to Web of Science.

"I am very excited to join the ADAA board and serve an association dedicated to improving the lives of individuals with depression and anxiety disorders. I am particularly interested in growing, retaining, and diversifying membership and fostering interdisciplinary initiatives."